What Happened?
Saint Laurent, Quebec-based Milestone Pharmaceuticals Appointed Debbie Everidge as Vice President Information Technology
About the Company
Milestone was founded in 2005 with the underlying concept to base its drug development programs on clinically validated mechanisms of action in order to mitigate as much drug development risk as possible. The company has raised a total of $34 million in venture capital financing since 2006. At its founding, the company assembled a panel of leading pharmaceutical R&D executives (“drug hunters”) each with an average of 30 years experience in drug development. The drug hunters proposed NCE projects based on clinically proven science to form the basis of Milestone’s drug development programs. Milestone has a seasoned management team with experience in cardiovascular diseases, drug development and business start-ups as well as world-class advisory boards of key opinion leaders with significant expertise in cardiology, regulatory affairs, as well as formulation and drug development.
About the Person
Debbie Everidge is Vice President Information Technology at Milestone Pharmaceuticals. Previously, Debbie held various senior IT leadership roles in the industry.
Info Source
News
Short Profile